Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.87 USD | -0.14% | -5.05% | +13.71% |
04-11 | Wells Fargo Raises Price Target on Ryan Specialty Group to $58 From $57, Keeps Overweight Rating | MT |
03-04 | UBS Raises Ryan Specialty Price Target to $62 From $57, Maintains Buy Rating | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 66% by 2026.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- For the past twelve months, EPS forecast has been revised upwards.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With an expected P/E ratio at 39.06 and 26.97 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Multiline Insurance & Brokers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.71% | 5.81B | - | ||
+3.80% | 51.16B | B- | ||
+4.39% | 25.66B | C+ | ||
+14.54% | 23.24B | C | ||
+20.85% | 9.56B | - | ||
-2.41% | 4.02B | B | ||
+3.24% | 1.99B | C+ | ||
+11.16% | 1.76B | C- | ||
-23.96% | 1.4B | C- | ||
+15.20% | 1.27B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- RYAN Stock
- Ratings Ryan Specialty Holdings, Inc.